Prognosis of ulcerative colitis colorectal cancer vs. sporadic colorectal cancer: propensity score matching analysis

Yoon Dae Han,Mahdi Hussain Al Bandar,Audrius Dulskas,Min Soo Cho,Hyuk Hur,Byung Soh Min,Kang Young Lee,Nam Kyu Kim

DOI: https://doi.org/10.1186/s12893-017-0224-z

2017-03-21

BMC Surgery

Abstract:BackgroundUlcerative colitis (UC) harbours a high risk of UC-associated colorectal cancer (UCCC), which is important cause of morbidity and mortality in patients with inflammatory bowel disease. Overall Survival (OS) of patients with UCCC has not been addressed well in the literature. Thus, we compared oncologic outcome of UCCC and sporadic colorectal cancer (SCC) using propensity score matching analysis.MethodsPropensity score matching was performed for 36 patients, a 1:1 matching method stratified into 18 in UCCC and 18 patients in SCC. Matched variables were sex, age, body mass index, tumour stage, histology, preoperative carcinoembryonic antigen (CEA) level, and adjuvant treatment status. Patients with SCC or UCCC were retrospectively retrieved from our database from March 2000 to December 2015. All patients had undergone either oncological segmental resection or total proctocolectomy.ResultsThe majority of cancers were found in the sigmoid colon. Total proctocolectomy was performed only in the UCCC group; however, half of the UCCC group underwent a standard operation. Five cases of postoperative complication occurred within six months in the UCCC group compared to one case in the SCC group. There was no significant difference in recurrence rate (p = 0.361) or OS (p = 0.896) between the arms.ConclusionUCCC showed more postoperative complications than SCC, and equivalent oncology outcome, however the difference was not statistically significant. This study represents an experience of a single institution, thus further randomized studies are required to confirm our.

surgery

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to compare the oncological outcomes of ulcerative colitis - related colorectal cancer (UCCC) and sporadic colorectal cancer (SCC), especially to evaluate the long - term prognosis and recurrence rate of both through propensity score - matching analysis. The research background indicates that patients with ulcerative colitis (UC) have a higher risk of UCCC, which is one of the important causes of death in patients with inflammatory bowel disease (IBD). However, the overall survival rate (OS) of UCCC patients is less discussed in the literature. Therefore, this study aims to fill this knowledge gap and explore whether there are significant differences between the two by comparing the oncological outcomes of UCCC and SCC patients.

The research methods include 1:1 propensity score - matching for 36 patients, who were stratified according to gender, age, body mass index, tumor stage, histological type, preoperative carcinoembryonic antigen (CEA) level and adjuvant treatment status. The study found that although there were more postoperative complications in the UCCC group, there was no significant difference in the recurrence rate or overall survival rate between the two groups. This indicates that although UCCC patients may face more postoperative challenges, they do not show obvious disadvantages compared with SCC patients in terms of oncological prognosis. However, the researchers also pointed out that since this is a single - center study and the sample size is relatively small, further randomized controlled studies are needed to confirm these findings.